Category:
Marketing / Sales OFFERED:
Date Posted:
more than 1 month ago (Not Renewed))
Description:
Launch of biosimilars in the erythropoietin market has increased its affordability. European region is the largest market for erythropoietin biosimilar, which makes it a major market for over all erythropoietin drugs as well. As per RNCOS report “European Erythropoietin Market Outlook 2022”, the market of Europe was valued at US$ 1.4 Billion in 2015. This report provides a detailed analysis of the current and future market scenario of the European erythropoietin market. The report highlights biosimilar erythropoietin at various stages of clinical development. In addition, the report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. Website: http://www.rncos.com/Market-Analysis-Reports/European-Erythropoietin-Market-Outlook-2022-IM863.htmPhone: 4224700/ 01/ 02/ 03
Province > County:
New York > New York